QR Kodea

Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma

Summary: The outcome of immune checkpoint blockade (ICB) therapy largely hinges on the antitumor immunity of tertiary lymphoid structures (TLSs), but drivers of tumor TLS formation remain exclusive. By integrating spatial transcriptomics and a pan-cancer single-cell atlas, we reveal the characterist...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shang-Xin Liu, Tao-Wei Wu, Dong-Hua Luo, Le-Le Zhang, Lu Zhou, Yi-Ling Luo, Wen-Ting Du, Ting-Ting Huang, Sizun Jiang, Zhe Zhang, Ping Han, Mu-Sheng Zeng, Qian Zhong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2025-07-01
Saila:Cell Reports Medicine
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2666379125002733
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!